Cargando…

Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema

INTRODUCTION: Angiotensin Converting Enzyme Inhibitors (ACEI) are a common cause of Emergency Room presentation for angioedema. Although no treatment guidelines exist, C1 esterase inhibitor concentrate (C1-INH) is used on an off label basis for management of ACEI acquired angioedema (ACEI AAE). OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovaltchouk, Uliana, Zhang, Boyang, Jain, Vipul, Kalicinsky, Chrystyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885369/ https://www.ncbi.nlm.nih.gov/pubmed/33588931 http://dx.doi.org/10.1186/s13223-021-00521-w

Ejemplares similares

Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant
por: Ho, Peter, et al.
Publicado: (2014)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
por: McKibbin, Lundy, et al.
Publicado: (2019)

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
por: Crooks, Neil H., et al.
Publicado: (2014)

Small Bowel Angioedema Secondary to Angiotensin-Converting Enzyme Inhibitors
por: Inayat, Faisal, et al.
Publicado: (2016)

Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
por: Oliveira, Ana Maria, et al.
Publicado: (2015)

Clinical and genetic features of hereditary angioedema with and without C1‐inhibitor (C1‐INH) deficiency in Japan
por: Hashimura, Chinami, et al.
Publicado: (2021)

Visceral Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: Case Report
por: Frutuoso, Beatriz, et al.
Publicado: (2015)

Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
por: Rasmussen, Eva Rye, et al.
Publicado: (2017)

The First Occurrence of Angioedema After Discontinuation of Angiotensin-Converting Enzyme Inhibitor
por: Kainat, Aleesha, et al.
Publicado: (2021)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
por: Bisinotto, Flora Margarida Barra, et al.
Publicado: (2019)

Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases
por: Motamed, Mohammad Reza, et al.
Publicado: (2015)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
por: Marques, Acílio, et al.
Publicado: (2014)

Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
por: Rasmussen, Eva Rye, et al.
Publicado: (2018)

Imaging Review of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema of the Head and Neck
por: Baig, Saif, et al.
Publicado: (2021)

Tranexamic Acid for the Emergency Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
por: Hasara, Shannon, et al.
Publicado: (2021)

COVID-19 and angiotensin-converting enzyme inhibitors from plant origin
por: Gharebaghi, Reza, et al.
Publicado: (2022)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients
por: Vura, Naga Venkata Rama Krishna, et al.
Publicado: (2021)

An Unusual Case of Angiotensin-Converting-Enzyme Inhibitor-Related Penile Angioedema with Evolution to the Oropharynx
por: Wagner, Jonathan G., et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitor-Induced Gastrointestinal Angioedema: The First Danish Case Report
por: Rincic Antulov, Marijana, et al.
Publicado: (2018)

Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report
por: Al-Hoqani, Zamzam Khalaf, et al.
Publicado: (2020)

A Case of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Small Bowel Angioedema
por: Pirzada, Sarmad, et al.
Publicado: (2023)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
por: Liu, Xiao, et al.
Publicado: (2020)

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
por: Rasmussen, Eva Rye, et al.
Publicado: (2020)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitor-Induced Small Bowel Angioedema: An Important Differential for Episodic Enteritis
por: Mingos, Nicholas, et al.
Publicado: (2022)

Unresolved Chronic Diarrhea: A Case of Angiotensin-Converting Enzyme Inhibitor-Induced Mesenteric Angioedema
por: Bharwad, Aastha, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema With Resultant Airway Obstruction Following Endotracheal Intubation
por: Vazirnia, Parsia, et al.
Publicado: (2023)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
por: Mateti, Uday Venkat, et al.
Publicado: (2014)

Angiotensin-converting enzyme inhibitor–associated angioedema treated with c1-esterase inhibitor: A case report and review of the literature
por: Erickson, Davis Lynn, et al.
Publicado: (2016)

Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition
por: Arman, Q.
Publicado: (2010)

Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
por: Fragnan, N.T.M.L., et al.
Publicado: (2018)

Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
por: Yeung, Erin K., et al.
Publicado: (2018)

Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: A case report
por: Jackeviciute, Jone, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5d03uso4d3r39kl4im6mmc5b9j